首页> 外国专利> ERYTHROCYTES SENSITIZED WITH A SINGLE IMMUNOGLOBULIN OR COMPLEMENT COMPONENT

ERYTHROCYTES SENSITIZED WITH A SINGLE IMMUNOGLOBULIN OR COMPLEMENT COMPONENT

机译:单免疫球蛋白或补体成分致敏的红细胞

摘要

A set of four cell suspensions containing erythrocytes monospecifically sensitized with IgG, IgM, C3, and C4. The suspensions provide control cells to determine the purity and strength of the antibodies to these immunoglobulins or complement components contained in antisera used for clinical testing. Strict control of the pH, temperature, and EDTA concentration of a solution to which blood is added allows for the elective production of C3- or C4- sensitized cells. Selecting a serum with IgG or IgM antibodies and inactivating undesired proteins permits the production IgG- or IgM-sensitized cells. The resultant cells have agglutination reaction strengths of about 2-4+. Erythrocytes from humans r other animals may undergo the monospecific sensitization. Other human proteins, such as IgA or C5, and plasma proteins from other animals may similarly be attached monospecifically to red blood cells.
机译:一组四个含有红细胞的细胞悬液,这些细胞被IgG,IgM,C3和C4单特异性致敏。悬浮液提供对照细胞,以确定针对这些免疫球蛋白或用于临床测试的抗血清中包含的补体成分的抗体的纯度和强度。严格控制添加了血液的溶液的pH,温度和EDTA浓度,可以选择性产生C3或C4致敏细胞。选择具有IgG或IgM抗体的血清并灭活不需要的蛋白质可以产生IgG或IgM致敏的细胞。所得细胞的凝集反应强度为约2-4 +。人类或其他动物的红细胞可能会发生单特异性致敏作用。类似地,其他人蛋白质,例如IgA或C5,以及来自其他动物的血浆蛋白质也可以类似地单特异性地附着在红细胞上。

著录项

  • 公开/公告号WO7900796A1

    专利类型

  • 公开/公告日1979-10-18

    原文格式PDF

  • 申请/专利权人 AMERICAN HOSPITAL SUPPLY CORP;

    申请/专利号WO1979US00121

  • 发明设计人

    申请日1979-02-28

  • 分类号G01N31/00;

  • 国家 WO

  • 入库时间 2022-08-22 20:08:00

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号